Farah Khorassani

435 total citations
12 papers, 274 citations indexed

About

Farah Khorassani is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Farah Khorassani has authored 12 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 2 papers in Clinical Psychology. Recurrent topics in Farah Khorassani's work include Bipolar Disorder and Treatment (4 papers), Schizophrenia research and treatment (4 papers) and Treatment of Major Depression (3 papers). Farah Khorassani is often cited by papers focused on Bipolar Disorder and Treatment (4 papers), Schizophrenia research and treatment (4 papers) and Treatment of Major Depression (3 papers). Farah Khorassani collaborates with scholars based in United States and Taiwan. Farah Khorassani's co-authors include Ana C. Ricardo, Joseph Mattana, Candace Grant, Shayan Shirazian, Anne Misher, Olga Hilas, Maha Saad, Demetra Tsapepas and John M. Conry and has published in prestigious journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy and Kidney International Reports.

In The Last Decade

Farah Khorassani

11 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farah Khorassani United States	6	98	75	69	33	30	12	274
Özen Önen Sertöz Türkiye	10	99 1.0×	85 1.1×	50 0.7×	17 0.5×	10 0.3×	29	395
Charmaine Cooke Canada	11	35 0.4×	42 0.6×	76 1.1×	10 0.3×	20 0.7×	22	258
Alison Bautovich Australia	4	62 0.6×	73 1.0×	163 2.4×	20 0.6×	100 3.3×	7	296
Anthony McGuire United States	8	76 0.8×	23 0.3×	74 1.1×	18 0.5×	14 0.5×	10	374
Milton L. Bullock United States	10	135 1.4×	59 0.8×	97 1.4×	67 2.0×	65 2.2×	11	638
Mariana Tatsch Brazil	7	90 0.9×	32 0.4×	238 3.4×	25 0.8×	18 0.6×	14	475
Kamini Vasudev Canada	12	22 0.2×	41 0.5×	308 4.5×	34 1.0×	54 1.8×	28	552
Keiko Kabasawa Japan	12	26 0.3×	24 0.3×	62 0.9×	16 0.5×	49 1.6×	36	313
Thomas E. Steele United States	14	149 1.5×	121 1.6×	180 2.6×	20 0.6×	59 2.0×	20	460
Mikkel Højlund Denmark	15	22 0.2×	162 2.2×	291 4.2×	30 0.9×	81 2.7×	44	608

Countries citing papers authored by Farah Khorassani

Since Specialization

Citations

This map shows the geographic impact of Farah Khorassani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farah Khorassani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farah Khorassani more than expected).

Fields of papers citing papers by Farah Khorassani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farah Khorassani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farah Khorassani. The network helps show where Farah Khorassani may publish in the future.

Co-authorship network of co-authors of Farah Khorassani

This figure shows the co-authorship network connecting the top 25 collaborators of Farah Khorassani. A scholar is included among the top collaborators of Farah Khorassani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farah Khorassani. Farah Khorassani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Khorassani, Farah, et al.. (2025). Special Report: Clozapine Revisited: Updates to the Gold Standard. Psychiatric News. 60(5).

Khorassani, Farah, et al.. (2024). Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review. Current Treatment Options in Psychiatry. 11(2). 123–140. 2 indexed citations

Khorassani, Farah, et al.. (2021). Evaluation of anxiety in doctor of pharmacy students in their first through fourth professional years. Currents in Pharmacy Teaching and Learning. 13(6). 628–634. 5 indexed citations

Khorassani, Farah, et al.. (2020). Intranasal esketamine: A novel drug for treatment-resistant depression. American Journal of Health-System Pharmacy. 77(17). 1382–1388. 12 indexed citations

Khorassani, Farah, et al.. (2020). Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature. American Journal of Health-System Pharmacy. 77(19). 1578–1584. 2 indexed citations

Khorassani, Farah, et al.. (2020). Valbenazine and deutetrabenazine: Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia. American Journal of Health-System Pharmacy. 77(3). 167–174. 11 indexed citations

Khorassani, Farah & Maha Saad. (2019). Intravenous Olanzapine for the Management of Agitation: Review of the Literature. Annals of Pharmacotherapy. 53(8). 853–859. 9 indexed citations

Khorassani, Farah, et al.. (2018). Pharmacist’s Role in Improving Medication Adherence in Transplant Recipients With Comorbid Psychiatric Disorders. Journal of Pharmacy Practice. 32(5). 568–578. 5 indexed citations

Khorassani, Farah, et al.. (2018). Cost Comparison of Atypical Antipsychotics: Paliperidone ER and Risperidone. Hospital Pharmacy. 54(6). 389–392. 2 indexed citations

10.

Shirazian, Shayan, et al.. (2016). Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management. Kidney International Reports. 2(1). 94–107. 195 indexed citations

11.

Khorassani, Farah, et al.. (2015). Past and present of antiobesity agents: Focus on monoamine modulators. American Journal of Health-System Pharmacy. 72(9). 697–706. 19 indexed citations

12.

Khorassani, Farah & Olga Hilas. (2013). Bapineuzumab, an investigational agent for Alzheimer's disease.. PubMed. 38(2). 89–91. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact